نتائج البحث - Friederike Schmidt‐Graf

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Mobile Apps in Oncology: A Survey on Health Care Professionals’ Attitude Toward Telemedicine, mHealth, and Oncological Apps

    Mobile Apps in Oncology: A Survey on Health Care Professionals’ Attitude Toward Telemedicine, mHealth, and Oncological Apps حسب Kerstin A. Kessel, Marco M. E. Vogel, Friederike Schmidt‐Graf, Stephanie E. Combs

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma

    Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma حسب Kerstin A. Kessel, Josefine Hesse, Christoph Straube, Claus Zimmer, Friederike Schmidt‐Graf, Jürgen Schlegel, Bernhard Meyer, Stephanie E. Combs

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

    Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma حسب Andrea Schäfer, Julian Teufel, Florian Ringel, Marcus Bettstetter, Ingrid Hoepner, Michael Rasper, Jens Gempt, Julia Koeritzer, Friederike Schmidt‐Graf, Bernhard Meyer, Christoph P. Beier, Jürgen Schlegel

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume

    Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume حسب Stefanie Bette, Melanie Barz, Thomas S. Huber, Christoph Straube, Friederike Schmidt‐Graf, Stephanie E. Combs, Claire Delbridge, Julia Gerhardt, Claus Zimmer, Bernhard Meyer, Jan S. Kirschke, Tobias Boeckh‐Behrens, Benedikt Wiestler, Jens Gempt

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

    Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide حسب Wolfgang Wick, Patrick Roth, Christian Hartmann, Peter Hau, Makoto Nakamura, Florian Stockhammer, Michael Sabel, Antje Wick, Susanne Koeppen, Ralf Ketter, Peter Vajkoczy, Ilker Y. Eyüpoglu, Rolf Kalff, Torsten Pietsch, Caroline Happold, Norbert Galldiks, Friederike Schmidt‐Graf, Michael Bamberg, Guido Reifenberger, Michael Platten, Andreas von Deimling, Christoph Meisner, Benedikt Wiestler, Michael Weller

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis

    DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis حسب Denise Bernhardt, Laila König, Anca‐Ligia Grosu, Benedikt Wiestler, Stefan Rieken, Wolfgang Wick, Jens Gempt, Sandro M. Krieg, Friederike Schmidt‐Graf, Felix Sahm, Bernhard Meyer, Bernd J. Krause, Cordula Petersen, Rainer Fietkau, Michael Thomas, Frank A. Giordano, Andrea Wittig-Sauerwein, Jürgen Debus, Ghazaleh Tabatabai, Peter Hau, Joachim P. Steinbach, Stephanie E. Combs

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

    Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a random... حسب Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf‐Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas E. Kowalski, Florian Ringel, Friederike Schmidt‐Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg‐Christian Tonn, Matthias Simon, Vera C. Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: